No Data
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
Barrington Reaffirms Their Buy Rating on Haemonetics (HAE)
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
Macroeconomic Woes, FX Headwind Drag NEOG Stock Down
Haemonetics Announces EVP Josep Llorens' Retirement